embolism (PE), have remained a pressing problem in modern clinical medicine for a long time. Despite

of the University Clinic was performed a prospective study of 107 patients with incisional hernia, who underwent a

, the persisting deficiencies and future prospects of using lncRNAs as clinical biomarkers and therapeutic targets

. The developed software can be used as a separate application and be built as a module into the clinical decision

and clinical applications are worth further examination. This article reviews the recent research on the role

(lncRNAs) and circular RNAs (circRNAs) into clinical medicine as biomarkers and therapeutic targets.

investigations and clinical trials employed enhanced MSCs-dependent therapies in treatment of inflammatory